NH HEALTH (NH HEALTH) announced on 28 March 2024 that due to the need for an independent investigation, due to certain concerns raised by Auditor, Dokian Guan Wong Chan Fang, on the effectiveness of the ColoClear and Pupu Tube or UU Tube sales transactions, the annual results for the year ended 31 December 2023 could not be published on time. The company has appointed third-party experts to conduct the investigation and is working with auditors and audit committees to resolve the issue. Due to the failure to publish financial results on time, the Board meeting originally scheduled for 28 March 2024 will be delayed. In addition, under the rules of the listing, the company's shares have been suspended from 28 March 2024 pending the announcement of the annual results.

NH HEALTH (NH HEALTH) announced on 28 March 2024 that due to the need for an independent investigation, due to certain concerns raised by Auditor, Dokian Guan Wong Chan Fang, on the effectiveness of the ColoClear and Pupu Tube or UU Tube sales transactions, the annual results for the year ended 31 December 2023 could not be published on time. The company has appointed third-party experts to conduct the investigation and is working with auditors and audit committees to resolve the issue. Due to the failure to publish financial results on time, the Board meeting originally scheduled for 28 March 2024 will be delayed. In addition, under the rules of the listing, the company's shares have been suspended from 28 March 2024 pending the announcement of the annual results.